Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
European Journal of Medicinal Chemistry
|
October 10, 2021
Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction
Rohit Pal, Karanvir Singh, Shah Alam Khan, et al.
Current Neuropharmacology
|
August 4, 2021
Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant Agents
Rohit Pal, Karanvir Singh, Joyson Paul, et al.
Chemistry & Biodiversity
|
August 11, 2023
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship
Ghanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
European Journal of Medicinal Chemistry
|
November 11, 2024
Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance
Ebna Azizal Omar, Rajesh R, Pronoy Kanti Das, et al.
Bioorganic Chemistry
|
November 17, 2022
Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship
Ganesh Prasad Shenoy, Rohit Pal, Gurubasavaraja Swamy Purwarga Matada, et al.
Bioorganic Chemistry
|
November 27, 2024
Recent advancements in mechanistic research, therapeutic potential, and structure-activity relationships of aurora kinase inhibitors in cancer therapies
Ghanshyam Teli, Lalmohan Maji, Rohit Pal, et al.
Molecular Diversity
|
July 20, 2023
An updated literature on BRAF inhibitors (2018-2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
European Journal of Medicinal Chemistry
|
January 1, 2026
Medicinal chemistry perspective on quinazoline derivatives: Sustainable synthetic routes, anticancer evaluation, and SAR analysis
Sudarshini Dutta, R Rajesh, P M Gurubasavaraja Swamy, et al.
Chemistry & Biodiversity
|
December 3, 2025
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives
Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal, et al.
Journal of Biomolecular Structure & Dynamics
|
May 9, 2023
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
European Journal of Medicinal Chemistry
|
October 10, 2021
Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction
Rohit Pal, Karanvir Singh, Shah Alam Khan, et al.
Current Neuropharmacology
|
August 4, 2021
Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant Agents
Rohit Pal, Karanvir Singh, Joyson Paul, et al.
Chemistry & Biodiversity
|
August 11, 2023
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship
Ghanshyam Teli, Rohit Pal, Lalmohan Maji, et al.
European Journal of Medicinal Chemistry
|
November 11, 2024
Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance
Ebna Azizal Omar, Rajesh R, Pronoy Kanti Das, et al.
Bioorganic Chemistry
|
November 17, 2022
Discoidin domain receptor inhibitors as anticancer agents: A systematic review on recent development of DDRs inhibitors, their resistance and structure activity relationship
Ganesh Prasad Shenoy, Rohit Pal, Gurubasavaraja Swamy Purwarga Matada, et al.
Bioorganic Chemistry
|
November 27, 2024
Recent advancements in mechanistic research, therapeutic potential, and structure-activity relationships of aurora kinase inhibitors in cancer therapies
Ghanshyam Teli, Lalmohan Maji, Rohit Pal, et al.
Molecular Diversity
|
July 20, 2023
An updated literature on BRAF inhibitors (2018-2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
European Journal of Medicinal Chemistry
|
January 1, 2026
Medicinal chemistry perspective on quinazoline derivatives: Sustainable synthetic routes, anticancer evaluation, and SAR analysis
Sudarshini Dutta, R Rajesh, P M Gurubasavaraja Swamy, et al.
Chemistry & Biodiversity
|
December 3, 2025
Steroidal Scaffolds as Anticancer Agents: Evolution, FDA Approvals, Synthetic Derivatives, SAR Profiles, and Translational Perspectives
Prabhugouda Gugal, Hemalatha Kamurthy, Rohit Pal, et al.
Journal of Biomolecular Structure & Dynamics
|
May 9, 2023
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review
Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Page
of 4